{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T10:11:27Z","timestamp":1794910287231,"version":"4.9.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"President's Emergency Plan for AIDS Relief","award":["1NU2GGH002046-01\u201300"],"award-info":[{"award-number":["1NU2GGH002046-01\u201300"]}]},{"name":"President's Emergency Plan for AIDS Relief","award":["1NU2GGH002046-01\u201300"],"award-info":[{"award-number":["1NU2GGH002046-01\u201300"]}]},{"name":"President's Emergency Plan for AIDS Relief","award":["1NU2GGH002046-01\u201300"],"award-info":[{"award-number":["1NU2GGH002046-01\u201300"]}]},{"name":"President's Emergency Plan for AIDS Relief","award":["1NU2GGH002046-01\u201300"],"award-info":[{"award-number":["1NU2GGH002046-01\u201300"]}]},{"name":"President's Emergency Plan for AIDS Relief","award":["1NU2GGH002046-01\u201300"],"award-info":[{"award-number":["1NU2GGH002046-01\u201300"]}]},{"name":"President's Emergency Plan for AIDS Relief","award":["1NU2GGH002046-01\u201300"],"award-info":[{"award-number":["1NU2GGH002046-01\u201300"]}]},{"name":"President's Emergency Plan for AIDS Relief","award":["1NU2GGH002046-01\u201300"],"award-info":[{"award-number":["1NU2GGH002046-01\u201300"]}]},{"name":"President's Emergency Plan for AIDS Relief","award":["1NU2GGH002046-01\u201300"],"award-info":[{"award-number":["1NU2GGH002046-01\u201300"]}]},{"name":"President's Emergency Plan for AIDS Relief","award":["1NU2GGH002046-01\u201300"],"award-info":[{"award-number":["1NU2GGH002046-01\u201300"]}]},{"name":"President's Emergency Plan for AIDS Relief","award":["1NU2GGH002046-01\u201300"],"award-info":[{"award-number":["1NU2GGH002046-01\u201300"]}]},{"name":"President's Emergency Plan for AIDS Relief","award":["1NU2GGH002046-01\u201300"],"award-info":[{"award-number":["1NU2GGH002046-01\u201300"]}]},{"name":"President's Emergency Plan for AIDS Relief","award":["1NU2GGH002046-01\u201300"],"award-info":[{"award-number":["1NU2GGH002046-01\u201300"]}]},{"name":"President's Emergency Plan for AIDS Relief","award":["1NU2GGH002046-01\u201300"],"award-info":[{"award-number":["1NU2GGH002046-01\u201300"]}]},{"name":"President's Emergency Plan for AIDS Relief","award":["1NU2GGH002046-01\u201300"],"award-info":[{"award-number":["1NU2GGH002046-01\u201300"]}]},{"name":"President's Emergency Plan for AIDS Relief","award":["1NU2GGH002046-01\u201300"],"award-info":[{"award-number":["1NU2GGH002046-01\u201300"]}]},{"name":"President's Emergency Plan for AIDS Relief","award":["1NU2GGH002046-01\u201300"],"award-info":[{"award-number":["1NU2GGH002046-01\u201300"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11397-1","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T13:55:39Z","timestamp":1754142939000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Factors associated with mortality among people with advanced HIV disease in rural uganda: a retrospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Kabali","family":"Bwogi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine Nassozi","family":"Lwanira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Kasamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Baruch","family":"Baluku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine K.","family":"Nakiwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Ndagire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Nassolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Wabomba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bwanika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Nakawesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Namayanja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kabanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius N.","family":"Kalamya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Ssempiira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Ssenyimba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Mulebeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur G.","family":"Fitzmaurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Mukasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,2]]},"reference":[{"key":"11397_CR1","unstructured":"The Global HIV\/AIDS Epidemic. KFF. 2023. https:\/\/www.kff.org\/global-health-policy\/fact-sheet\/the-global-hiv-aids-epidemic\/. Accessed 12 Jan 2024."},{"key":"11397_CR2","unstructured":"Global HIV. & AIDS statistics\u2014Fact sheet. https:\/\/www.unaids.org\/en\/resources\/fact-sheet. Accessed 13 Jan 2024."},{"key":"11397_CR3","unstructured":"World Health Organization. HIV data and statistics. https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/strategic-information\/hiv-data-and-statistics. Accessed 28 May 2025."},{"key":"11397_CR4","unstructured":"Uganda AIDS. Commission. Uganda AIDS Commission| We share challenges together| Ending HIV\/AIDS by 2030. https:\/\/uac.go.ug\/. Accessed 31 Aug 2024."},{"issue":"suppl2","key":"11397_CR5","doi-asserted-by":"publisher","first-page":"S132","DOI":"10.1093\/cid\/cix1141","volume":"66","author":"FA Post","year":"2018","unstructured":"Post FA, Szubert AJ, Prendergast AJ, Johnston V, Lyall H, Fitzgerald F, et al. Causes and timing of mortality and morbidity among late presenters starting antiretroviral therapy in the REALITY trial. Clin Infect Dis. 2018;66(suppl2):S132\u20139.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"11397_CR6","doi-asserted-by":"publisher","first-page":"e1001718","DOI":"10.1371\/journal.pmed.1001718","volume":"11","author":"A Boulle","year":"2014","unstructured":"Boulle A, Schomaker M, May MT, Hogg RS, Shepherd BE, Monge S, et al. Mortality in patients with HIV-1 infection starting antiretroviral therapy in South africa, europe, or North america: A collaborative analysis of prospective studies. Binagwaho A, editor. PLoS Med. 2014;11(9):e1001718.","journal-title":"PLoS Med"},{"issue":"5","key":"11397_CR7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/QAI.0000000000002786","volume":"88","author":"VQ Dat","year":"2021","unstructured":"Dat VQ, Lyss S, Dung NTH, Hung LM, Pals SL, Anh HTV, et al. Prevalence of advanced HIV disease, Cryptococcal antigenemia, and suboptimal clinical outcomes among those enrolled in care in Vietnam. JAIDS J Acquir Immune Defic Syndr. 2021;88(5):487\u201396.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"12","key":"11397_CR8","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1093\/cid\/cis797","volume":"55","author":"AS Walker","year":"2012","unstructured":"Walker AS, Prendergast AJ, Mugyenyi P, Munderi P, Hakim J, Kekitiinwa A, et al. Mortality in the year following antiretroviral therapy initiation in HIV-Infected adults and children in Uganda and Zimbabwe. Clin Infect Dis. 2012;55(12):1707\u201318.","journal-title":"Clin Infect Dis"},{"key":"11397_CR9","unstructured":"Advanced HIV. disease (AHD). https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/treatment\/advanced-hiv-disease. Accessed 31 Aug 2024."},{"issue":"4","key":"11397_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/cid\/ciab995","volume":"75","author":"H Kibuuka","year":"2021","unstructured":"Kibuuka H, Musingye E, Mwesigwa B, Semwogerere M, Iroezindu M, Bahemana E, et al. Predictors of All-Cause mortality among people with human immunodeficiency virus (HIV) in a prospective cohort study in East Africa and Nigeria. Clin Infect Dis Off Publ Infect Dis Soc Am. 2021;75(4):657\u201364.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"0","key":"11397_CR11","first-page":"1","volume":"0","author":"A Byamukama","year":"2022","unstructured":"Byamukama A, Golding PM. Predictors of mortality among people living with HIV in the test and treat era within rural uganda: a retrospective cohort study. Afr J AIDS Res. 2022;0(0):1\u20138.","journal-title":"Afr J AIDS Res"},{"key":"11397_CR12","unstructured":"World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. Geneva: World Health Organization. 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240031593."},{"issue":"Supplement 4","key":"11397_CR13","doi-asserted-by":"publisher","first-page":"S533","DOI":"10.1097\/QAD.0000000000000496","volume":"28","author":"G Reniers","year":"2014","unstructured":"Reniers G, Slaymaker E, Nakiyingi-Miiro J, Nyamukapa C, Crampin AC, Herbst K, et al. Mortality trends in the era of antiretroviral therapy: evidence from the network for analysing longitudinal population based HIV\/AIDS data on Africa (ALPHA). AIDS. 2014;28(Supplement 4):S533\u201342.","journal-title":"AIDS"},{"key":"11397_CR14","doi-asserted-by":"publisher","unstructured":"Baldeh M, Kizito S, Lakoh S, Sesay D, Dennis F, Barrie U et al. Prevalence and factors associated with advanced HIV disease among young people aged 15\u201324 years in a national referral hospital in Sierra Leone: a cross-sectional study. 2023. https:\/\/doi.org\/10.1101\/2023.11.07.23296880. Accessed 31 Aug 2024.","DOI":"10.1101\/2023.11.07.23296880"},{"issue":"1","key":"11397_CR15","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1186\/s12879-023-08521-4","volume":"23","author":"MK Kitenge","year":"2023","unstructured":"Kitenge MK, Fatti G, Eshun-Wilson I, Aluko O, Nyasulu P. Prevalence and trends of advanced HIV disease among antiretroviral therapy-na\u00efve and antiretroviral therapy-experienced patients in South Africa between 2010\u20132021: a systematic review and meta-analysis. BMC Infect Dis. 2023;23(1):549.","journal-title":"BMC Infect Dis"},{"key":"11397_CR16","unstructured":"Uganda_Consolidated HIV, Guidelines AIDS. 2020 June 30th.pdf. https:\/\/differentiatedservicedelivery.org\/Portals\/0\/adam\/Content\/HvpzRP5yUUSdpCe2m0KMdQ\/File\/Uganda_Consolidated%20HIV%20and%20AIDS%20Guidelines%202020%20June%2030th.pdf. Accessed 7 Oct 2022."},{"key":"11397_CR17","unstructured":"World Health Organization. Data quality assessment of national and partner HIV treatment and patient monitoring data and systems: implementation tool. 2018. https:\/\/iris.who.int\/handle\/10665\/274287. Accessed 28 May 2025."},{"key":"11397_CR18","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.actatropica.2016.05.009","volume":"165","author":"C Acup","year":"2017","unstructured":"Acup C, Bardosh KL, Picozzi K, Waiswa C, Welburn SC. Factors influencing passive surveillance for T. B. rhodesiense human African trypanosomiasis in Uganda. Acta Trop. 2017;165:230\u20139.","journal-title":"Acta Trop"},{"issue":"Suppl 2","key":"11397_CR19","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1093\/cid\/cix1139","volume":"66","author":"N Ford","year":"2018","unstructured":"Ford N, Meintjes G, Calmy A, Bygrave H, Migone C, Vitoria M, et al. Managing advanced HIV disease in a public health approach. Clin Infect Dis Off Publ Infect Dis Soc Am. 2018;66(Suppl 2):S106\u2013SS110.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"1","key":"11397_CR20","doi-asserted-by":"publisher","first-page":"18932","DOI":"10.7448\/IAS.17.1.18932","volume":"17","author":"C Munthali","year":"2014","unstructured":"Munthali C, Taegtmeyer M, Garner PG, Lalloo DG, Squire SB, Corbett EL, et al. Diagnostic accuracy of the WHO clinical staging system for defining eligibility for ART in sub-Saharan africa: a systematic review and meta-analysis. J Int AIDS Soc. 2014;17(1):18932.","journal-title":"J Int AIDS Soc"},{"key":"11397_CR21","first-page":"1","volume-title":"Policy brief","author":"The Role of HIV Viral Suppression in Reducing Transmission and Improving Individual Health","year":"2022","unstructured":"The Role of HIV Viral Suppression in Reducing Transmission and Improving Individual Health. Policy brief. 1st ed. Geneva: World Health Organization; 2022. p. 1.","edition":"1"},{"issue":"15","key":"11397_CR22","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1097\/QAD.0000000000002701","volume":"34","author":"MJ Vinikoor","year":"2020","unstructured":"Vinikoor MJ, Hachaambwa L. Advanced HIV disease during the \u2018treat all\u2019 era in Botswana. AIDS. 2020;34(15):2321\u20133.","journal-title":"AIDS"},{"issue":"12","key":"11397_CR23","doi-asserted-by":"publisher","first-page":"ofac611","DOI":"10.1093\/ofid\/ofac611","volume":"9","author":"L St\u00f6ger","year":"2022","unstructured":"St\u00f6ger L, Katende A, Mapesi H, Kalinjuma AV, Van Essen L, Klimkait T, et al. Persistent high burden and mortality associated with advanced HIV disease in rural Tanzania despite uptake of world health organization test and treat guidelines. Open Forum Infect Dis. 2022;9(12):ofac611.","journal-title":"Open Forum Infect Dis"},{"key":"11397_CR24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.puhe.2023.11.025","volume":"227","author":"SS Li","year":"2024","unstructured":"Li SS, Li K, Chen HH, Zhu QY, He JS, Feng Y, et al. Evaluation of factors associated with high advanced HIV disease and mortality in Southwestern china: a retrospective cohort study, 2005\u20132020. Public Health. 2024;227:282\u201390.","journal-title":"Public Health"},{"key":"11397_CR25","unstructured":"Understanding measures of progress towards the 95-. 95-95 HIV testing, treatment and viral suppression targets. https:\/\/www.unaids.org\/en\/resources\/documents\/2024\/progress-towards-95-95-95. Accessed 31 Aug 2024."},{"issue":"1","key":"11397_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40249-023-01119-7","volume":"12","author":"X Wu","year":"2023","unstructured":"Wu X, Wu G, Ma P, Wang R, Li L, Sun Y, et al. Immediate and long-term outcomes after treat-all among people living with HIV in china: an interrupted time series analysis. Infect Dis Poverty. 2023;12(1):73.","journal-title":"Infect Dis Poverty"},{"key":"11397_CR27","unstructured":"Uganda Viral Load Dashboard. https:\/\/vldash.cphluganda.org\/. Accessed 21 Sep 2024."},{"issue":"3","key":"11397_CR28","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1615822","volume":"377","author":"J Hakim","year":"2017","unstructured":"Hakim J, Musiime V, Szubert AJ, Mallewa J, Siika A, Agutu C, et al. Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa. N Engl J Med. 2017;377(3):233\u201345.","journal-title":"N Engl J Med"},{"key":"11397_CR29","doi-asserted-by":"crossref","unstructured":"Eduardo E, Lamb MR, Kandula S, Howard A, Mugisha V, Kimanga D et al. Characteristics and outcomes among older HIV-positive adults enrolled in HIV programs in four sub-Saharan African countries. Thorne C, editor. PLoS ONE. 2014;9(7):e103864.","DOI":"10.1371\/journal.pone.0103864"},{"issue":"1","key":"11397_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1042\/CS20210344","volume":"136","author":"M Chauvin","year":"2022","unstructured":"Chauvin M, Sauce D. Mechanisms of immune aging in HIV. Clin Sci. 2022;136(1):61\u201380.","journal-title":"Clin Sci"},{"key":"11397_CR31","unstructured":"World Health Organization. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy, July 2017. Geneva: World Health Organization. 2017. 56 p. https:\/\/iris.who.int\/handle\/10665\/255884. Accessed 19 Apr 2025."},{"key":"11397_CR32","unstructured":"Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services; 2024 [cited 2025 May 28]. https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/adult-and-adolescent-arv. Accessed 28 May 2025."},{"issue":"1","key":"11397_CR33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12981-020-00296-x","volume":"17","author":"AT Boyd","year":"2020","unstructured":"Boyd AT, Oboho I, Paulin H, Ali H, Godfrey C, Date A, et al. Addressing advanced HIV disease and mortality in global HIV programming. AIDS Res Ther. 2020;17(1):40.","journal-title":"AIDS Res Ther"},{"key":"11397_CR34","first-page":"117863372097063","volume":"13","author":"P Wakooko","year":"2020","unstructured":"Wakooko P, Gavamukulya Y, Wandabwa JN. Viral load suppression and associated factors among HIV patients on antiretroviral treatment in Bulambuli district, Eastern uganda: A retrospective cohort study. Infect Dis. 2020;13:1178633720970632.","journal-title":"Infect Dis"},{"key":"11397_CR35","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1097\/00126334-200212153-00005","volume":"31","author":"N Press","year":"2002","unstructured":"Press N, Tyndall MW, Wood E, Hogg RS, Montaner JSG. Virologic and Immunologic response, clinical progression, and highly active antiretroviral therapy adherence. JAIDS J Acquir Immune Defic Syndr. 2002;31:S112\u20137.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"11397_CR36","unstructured":"Laboratory, Testing. Plasma HIV-1 RNA (Viral Load) and CD4 Count Monitoring| NIH. 2022. https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-arv\/plasma-hiv-1-rna-cd4-monitoring. Accessed 22 Apr 2025."},{"key":"11397_CR37","unstructured":"Uganda| UNAIDS. 2025. https:\/\/www.unaids.org\/en\/regionscountries\/countries\/uganda. Accessed 22 Apr 2025."},{"key":"11397_CR38","doi-asserted-by":"publisher","first-page":"205031212311623","DOI":"10.1177\/20503121231162354","volume":"11","author":"R Nyaboke","year":"2023","unstructured":"Nyaboke R, Ramadhani HO, Lascko T, Awuor P, Kirui E, Koech E, et al. Factors associated with adherence and viral suppression among patients on second-line antiretroviral therapy in an urban HIV program in Kenya. SAGE Open Med. 2023;11:205031212311623.","journal-title":"SAGE Open Med"},{"key":"11397_CR39","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.2147\/HIV.S345731","volume":"13","author":"A Mwangi","year":"2021","unstructured":"Mwangi A, Van Wyk B. Factors associated with viral suppression among adolescents on antiretroviral therapy in homa Bay county, kenya: A retrospective Cross-Sectional study. HIVAIDS - Res Palliat Care. 2021;13:1111\u20138.","journal-title":"HIVAIDS - Res Palliat Care"},{"key":"11397_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ijid.2020.05.097","volume":"97","author":"EK Maina","year":"2020","unstructured":"Maina EK, Mureithi H, Adan AA, Muriuki J, Lwembe RM, Bukusi EA. Incidences and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya. Int J Infect Dis. 2020;97:151\u20138.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"11397_CR41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/00042560-200205010-00014","volume":"30","author":"PG De Olalla","year":"2002","unstructured":"De Olalla PG, Knobel H, Carmona A, Guelar A, L\u00f3pez-Colom\u00e9s JL, Cayl\u00e0 JA. Impact of adherence and highly active antiretroviral therapy on survival in HIV-Infected patients. JAIDS J Acquir Immune Defic Syndr. 2002;30(1):105\u201310.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"1","key":"11397_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s41043-019-0194-0","volume":"38","author":"KH Misgina","year":"2019","unstructured":"Misgina KH, Weldu MG, Gebremariam TH, Weledehaweria NB, Alema HB, Gebregiorgis YS, et al. Predictors of mortality among adult people living with HIV\/AIDS on antiretroviral therapy at Suhul hospital, tigrai, Northern ethiopia: a retrospective follow-up study. J Health Popul Nutr. 2019;38(1):37.","journal-title":"J Health Popul Nutr"},{"key":"11397_CR43","doi-asserted-by":"crossref","unstructured":"Sime T, Oljira L, Diriba A, Firdisa G, Gezimu W. Effect of active tuberculosis on the survival of HIV-infected adult patients who initiated antiretroviral therapy at public hospitals of Eastern Ethiopia: a retrospective cohort study. PLOS ONE. 2022;17(10):e0277021.","DOI":"10.1371\/journal.pone.0277021"},{"key":"11397_CR44","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2147\/HIV.S309018","volume":"13","author":"A Birhanu","year":"2021","unstructured":"Birhanu A, Dingeta T, Tolera M. Predictors of mortality among adult HIV-Infected patients taking antiretroviral therapy (ART) in Harari hospitals, Ethiopia. HIVAIDS - Res Palliat Care. 2021;13727\u201336.<\\\/p>","journal-title":"HIVAIDS - Res Palliat Care"},{"key":"11397_CR45","doi-asserted-by":"crossref","unstructured":"Kabami J, Owaraganise A, Beesiga B, Okiring J, Kakande E, Chen YH et al. Effect of the COVID-19 lockdown on the HIV care continuum in Southwestern Uganda: A time series analysis. PLOS ONE. 2023;18(8):e0289000.","DOI":"10.1371\/journal.pone.0289000"},{"issue":"5","key":"11397_CR46","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/QAI.0000000000002811","volume":"88","author":"Z Wagner","year":"2021","unstructured":"Wagner Z, Mukasa B, Nakakande J, Stecher C, Saya U, Linnemayr S. Impact of the COVID-19 pandemic on use of HIV care, antiretroviral therapy adherence, and viral suppression: an observational cohort study from Uganda. JAIDS J Acquir Immune Defic Syndr. 2021;88:(5):448\u201356.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"1","key":"11397_CR47","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s10461-020-03032-8","volume":"25","author":"S Linnemayr","year":"2021","unstructured":"Linnemayr S, Jennings Mayo-Wilson L, Saya U, Wagner Z, MacCarthy S, Walukaga S, et al. HIV care experiences during the COVID-19 pandemic: Mixed-Methods telephone interviews with Clinic-Enrolled HIV-Infected adults in Uganda. AIDS Behav. 2021;25(1):28\u201339.","journal-title":"AIDS Behav"},{"issue":"3","key":"11397_CR48","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.4269\/ajtmh.20-0546","volume":"103","author":"D Bell","year":"2020","unstructured":"Bell D, Hansen KS, Kiragga AN, Kambugu A, Kissa J, Mbonye AK. Predicting the impact of COVID-19 and the potential impact of the public health response on disease burden in Uganda. Am J Trop Med Hyg. 2020;103(3):1191\u20137.","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"11397_CR49","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1007\/s10461-023-04090-4","volume":"27","author":"NC Ware","year":"2023","unstructured":"Ware NC, Wyatt MA, Pisarski EE, Nalumansi A, Kasiita V, Kamusiime B, et al. How central Ugandan HIV clinics adapted during COVID-19 lockdown restrictions to promote continuous access to care: A qualitative analysis. AIDS Behav. 2023;27(11):3725\u201334.","journal-title":"AIDS Behav"},{"key":"11397_CR50","unstructured":"aidsmap.com. 2022. COVID-19 pandemic restrictions did not harm HIV care outcomes in Uganda. https:\/\/www.aidsmap.com\/news\/may-2022\/covid-19-pandemic-restrictions-did-not-harm-hiv-care-outcomes-uganda. Accessed 26 Jun 2025."},{"issue":"4","key":"11397_CR51","doi-asserted-by":"publisher","first-page":"e0408","DOI":"10.15275\/rusomj.2018.0408","volume":"7","author":"YZ Bekmukhambetov","year":"2018","unstructured":"Bekmukhambetov YZ, Mynbaev OA, Tinelli A, Balmagambetova SK, Koyshybaev AK, Urazayev ON, et al. Human papillomavirus related issues in Western kazakhstan: protocol for a comprehensive study. Russ Open Med J. 2018;7(4):e0408.","journal-title":"Russ Open Med J"},{"key":"11397_CR52","doi-asserted-by":"crossref","unstructured":"Shi Z, Li X, Yang Y. Obstetrical management of fulminant viral hepatitis in late pregnancy. Reprod Syst Sex Disord. 2012;01(01). https:\/\/www.omicsonline.org\/obstetrical-management-of-fulminant-viral-hepatitis-in-late-pregnancy-2161-038X.1000102.php?aid=3644. Accessed 4 Jul 2025.","DOI":"10.4172\/2161-038X.1000102"},{"issue":"4","key":"11397_CR53","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2478\/jtim-2024-0015","volume":"12","author":"J Wu","year":"2024","unstructured":"Wu J, Wang H, Xiang Z, Jiang C, Xu Y, Zhai G, et al. Role of viral hepatitis in pregnancy and its triggering mechanism. J Transl Intern Med. 2024;12(4):344\u201354.","journal-title":"J Transl Intern Med"},{"issue":"10","key":"11397_CR54","first-page":"1452","volume":"26","author":"Y Yin","year":"2006","unstructured":"Yin Y, zhu, Chen X, wei, Li X, mao, Hou Hying. Shi Z jie. [Intrauterine HBV infection: risk factors and impact of HBV DNA]. Nan Fang Yi Ke Da Xue Xue Bao. 2006;26(10):1452\u20134.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11397-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11397-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11397-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T12:19:44Z","timestamp":1757333984000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11397-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,2]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11397"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11397-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6328943\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,2]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics declarations"}},{"value":"This activity was reviewed and approved by Mildmay Uganda Institutional Review Board (REC REF No. 0804\u20132018), as well as the U.S Centers for Disease Control and Prevention (U.S CDC) under 45\u00a0C.F.R. part 46.101(c); 21\u00a0C.F.R. part 56. The data used were aggregated and individual patients could not be identified. We therefore did not seek informed consent. The Mildmay Uganda Research and Ethics committee provided a waiver of consent for the use of secondary data, because data were sourced from publicly accessible Electronic Medical Records (EMR) platform. All methods were performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"976"}}